Non-alcoholic fatty liver disease: A patient guideline

Multistakeholder NAFLD guideline—co-developed by patients, patient representatives, clinicians, and scientists—summarizes current care pathways. The emerging noninvasive tests section highlights multiparametric MRI as a promising tool to identify NASH with fibrosis, referencing Schaapman et al. (2020), which integrated LiverMultiScan cT1 into a clinical risk-assessment algorithm for NAFLD.